SHANK2
Basic information
Region (hg38): 11:70467854-71252577
Previous symbols: [ "CORTBP1" ]
Links
Phenotypes
GenCC
Source:
- autism, susceptibility to, 17 (Strong), mode of inheritance: AD
- autism, susceptibility to, 17 (Strong), mode of inheritance: AD
- complex neurodevelopmental disorder (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Autism, susceptibility to 17 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 20473310 |
ClinVar
This is a list of variants' phenotypes submitted to
- Autism, susceptibility to, 17 (5 variants)
- not provided (5 variants)
- Autism spectrum disorder (2 variants)
- Rare disease with autism (2 variants)
- Global developmental delay (1 variants)
- Neurodevelopmental disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SHANK2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 13 | 58 | 78 | |||
missense | 107 | 35 | 149 | |||
nonsense | 12 | |||||
start loss | 0 | |||||
frameshift | 27 | |||||
inframe indel | 3 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 4 | 4 | 1 | 9 | ||
non coding | 20 | 31 | ||||
Total | 14 | 12 | 157 | 103 | 16 |
Highest pathogenic variant AF is 0.00000657
Variants in SHANK2
This is a list of pathogenic ClinVar variants found in the SHANK2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-70468492-T-A | Autism spectrum disorder | Likely benign (Jun 14, 2016) | ||
11-70468767-G-C | Autism spectrum disorder | Likely benign (Jun 14, 2016) | ||
11-70468840-T-G | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70468922-G-C | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70469394-G-C | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70469623-C-T | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70469624-A-G | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70469802-T-C | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70470286-A-G | Autism spectrum disorder | Likely benign (Jun 14, 2016) | ||
11-70471272-A-C | Autism spectrum disorder | Likely benign (Jun 14, 2016) | ||
11-70471324-A-C | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70471335-C-CA | Autism spectrum disorder | Conflicting classifications of pathogenicity (Jan 01, 2023) | ||
11-70471847-A-G | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70472278-G-T | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70472284-G-A | Autism spectrum disorder | Uncertain significance (Jun 14, 2016) | ||
11-70472890-C-G | SHANK2-related disorder | Uncertain significance (May 28, 2024) | ||
11-70472925-G-A | Uncertain significance (Mar 17, 2014) | |||
11-70472944-G-A | not specified | Uncertain significance (Jun 01, 2015) | ||
11-70472947-G-GT | Inborn genetic diseases | Uncertain significance (Jan 25, 2022) | ||
11-70472966-GGTAA-G | not specified | Uncertain significance (Sep 13, 2017) | ||
11-70472983-G-A | Benign (Sep 01, 2022) | |||
11-70473043-G-A | not specified | Likely benign (Aug 03, 2017) | ||
11-70473102-T-C | not specified | Uncertain significance (Jan 31, 2018) | ||
11-70473141-G-A | Uncertain significance (Feb 25, 2022) | |||
11-70473145-C-T | Likely benign (Jan 01, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
SHANK2 | protein_coding | protein_coding | ENST00000338508 | 33 | 649663 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
8.43e-7 | 1.00 | 125731 | 0 | 2 | 125733 | 0.00000795 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.32 | 923 | 1.14e+3 | 0.807 | 0.0000800 | 12010 |
Missense in Polyphen | 186 | 266.31 | 0.69843 | 2734 | ||
Synonymous | -0.224 | 523 | 517 | 1.01 | 0.0000427 | 3812 |
Loss of Function | 5.51 | 26 | 78.8 | 0.330 | 0.00000459 | 884 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000176 | 0.0000176 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Seems to be an adapter protein in the postsynaptic density (PSD) of excitatory synapses that interconnects receptors of the postsynaptic membrane including NMDA-type and metabotropic glutamate receptors, and the actin-based cytoskeleton. May play a role in the structural and functional organization of the dendritic spine and synaptic junction.;
- Disease
- DISEASE: Autism 17 (AUTS17) [MIM:613436]: A complex multifactorial, pervasive developmental disorder characterized by impairments in reciprocal social interaction and communication, restricted and stereotyped patterns of interests and activities, and the presence of developmental abnormalities by 3 years of age. Most individuals with autism also manifest moderate mental retardation. {ECO:0000269|PubMed:20473310}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.;
- Pathway
- Glutamatergic synapse - Homo sapiens (human);Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.350
- hipred
- Y
- hipred_score
- 0.682
- ghis
- 0.630
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.788
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Shank2
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); growth/size/body region phenotype;
Gene ontology
- Biological process
- synapse assembly;learning;adult behavior;social behavior;brain morphogenesis;synaptic growth at neuromuscular junction;positive regulation of synaptic transmission, glutamatergic;long-term synaptic potentiation;long-term synaptic depression;dendritic spine morphogenesis;positive regulation of dendritic spine development;vocalization behavior;postsynaptic density assembly;regulation of AMPA receptor activity;positive regulation of excitatory postsynaptic potential
- Cellular component
- photoreceptor outer segment;photoreceptor inner segment;cellular_component;cytosol;neurofilament;plasma membrane;ionotropic glutamate receptor complex;postsynaptic density;apical plasma membrane;cell junction;dendrite;growth cone;brush border membrane;neuron projection;neuronal cell body;dendritic spine;neuron spine;postsynaptic membrane;ciliary membrane
- Molecular function
- protein binding;SH3 domain binding;receptor signaling complex scaffold activity;GKAP/Homer scaffold activity;ionotropic glutamate receptor binding